PacingCure B.V.
PrivateLast Round
Grant
Nov 22, 2022
Total Funding Raised
$2.91M
Company Overview
PacingCure B.V. is a biotechnology company that develops precision gene therapies for cardiac arrhythmias and cardiomyopathies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PacingCure B.V. Comparables
Compare PacingCure B.V. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioPace | 80% | |
| Medera | 72% | |
| Renova Therapeutics | 69% |
PacingCure B.V. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 22, 2022 | ||||
| Accelerator | Nov 26, 2020 | ||||
| Convertible Debt | Dec 18, 2019 |
Key People
Founding team and executive leadership
PacingCure B.V. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Innovatiefonds Noord-Holland | Convertible Debt |
| Life Sciences @ Work Venture Challenge | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 22, 2022
Secured $2.55M from the European Innovation Council Fund.
PacingCure B.V. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access